ALK and adenocarcinoma: There are well-known facts on the association of NSCLC genotypes with such factors, e.g., EGFR mutations and ALK fusions prevail in female patients with adenocarcinoma of younger age and no history of smoking, while KRAS mutations are more common in smokers (35).